| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 20.58B | 17.74B | 17.35B | 14.61B | 13.24B | 10.05B |
| Gross Profit | 2.74B | 2.00B | 2.40B | 2.17B | 1.74B | 779.08M |
| EBITDA | 2.52B | 2.11B | 2.22B | 1.65B | 1.55B | 798.84M |
| Net Income | 2.44B | 44.55M | 488.54M | 493.74M | 432.22M | -513.11M |
Balance Sheet | ||||||
| Total Assets | 27.89B | 16.32B | 15.55B | 14.04B | 11.22B | 10.27B |
| Cash, Cash Equivalents and Short-Term Investments | 6.42B | 1.50B | 1.67B | 1.35B | 2.28B | 1.12B |
| Total Debt | 4.16B | 3.04B | 3.69B | 2.84B | 1.96B | 1.87B |
| Total Liabilities | 16.11B | 9.24B | 9.50B | 8.77B | 6.39B | 5.84B |
| Stockholders Equity | 10.55B | 7.03B | 6.00B | 5.24B | 4.80B | 4.38B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -854.62M | -471.26M | -1.58B | 1.28B | -832.49M |
| Operating Cash Flow | 0.00 | 761.37M | 2.03B | 876.39M | 1.99B | 807.69M |
| Investing Cash Flow | 0.00 | -1.08B | -2.55B | -2.58B | -887.82M | -1.71B |
| Financing Cash Flow | 0.00 | 124.98M | 818.85M | 863.59M | 80.92M | 18.13M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
75 Outperform | ¥13.69B | 6.74 | ― | 3.90% | -1.72% | 168.62% | |
71 Outperform | ¥51.47B | 4.34 | ― | 3.60% | 0.14% | 882.91% | |
71 Outperform | ¥18.75B | 8.04 | ― | 2.70% | -8.63% | -55.68% | |
70 Outperform | ¥56.34B | 14.59 | ― | 0.99% | -0.83% | -27.20% | |
62 Neutral | ¥19.56B | -234.95 | ― | 4.58% | 34.99% | 468.97% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
57 Neutral | ¥18.89B | 18.77 | ― | 3.19% | -8.99% | -62.26% |